Chemclin Diagnostics Co., Ltd. (688468.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.96B |
| Enterprise Value | 3.04B |
| P/E Ratio | 71.97 |
| PEG Ratio | -1.29 |
| Price/Sales Ratio | 7.54 |
| Price/Book Ratio | 1.4 |
| Enterprise/Revenue | 7.74 |
| Enterprise/EBITDA | 28.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.11 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 330.38M |
| Revenue/Share | 0.98 |
| Gross Profit | 198.38M |
| EBITDA | 112.73M |
| Net Income | 43.91M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 513.88M |
| Total Cash/Share | 1.56 |
| Total Debt | 229.85M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 4.16 |
| Book Value Per Share | 4.34 |
Price History
| 52-Week Change | -22.51 |
| 52-Week High | 8.55 |
| 52-Week Low | 5.5 |
| Moving Average 50 Days | 6.41 |
| Moving Average 200 Days | 6.87 |
Statistics
| Average Volume | 2.97M |
| Shares Outstanding | 401.11M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.1 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
